Aerobiotix

Ohio, United States Founded: 2013 • Age: 13 yrs
UV-based disinfection systems are supplied for hospitals and facilities.

About Aerobiotix

Aerobiotix is a Healthcare company based in United States founded in 2013 by David Kirschman. UV-based disinfection systems are supplied for hospitals and facilities. Aerobiotix has raised $25 million across 1 funding round from investors including Vivo Capital and Asahi Kasei Ventures. Aerobiotix offers products and services including Illuvia Sense, AeroCure Vac, AeroCure 200, and GermZone Pro. Its focus areas include Life Sciences, Hospital Equipment, Hospital Infection Control and Air Sanitization. Its legal entity is AEROBIOTIX, LLC. Its competitors include R-Zero, Crystal IS and RayVio; 3 of its 3 listed competitors have raised funding.

Company details

Provider of UV-based disinfection systems for hospitals and other establishments. The products in Healthcare include Illuvia (air treatment systems), GermZone (upper room UV air Germicidal Systems), and GermVac (Negative pressure germicidal system). The Homecare product contains physician-designed laboratory-proven technology- Aerocure. The HVAC product is the Ultra V 250UV. The first product of the company was Tower One (T1) designed for air purification and disinfection system.

Key Metrics
  • Total Equity Funding
    $25M (USD)

    in 1 rounds

  • Latest Funding Round
    $25M (USD), Series A

    May 2021

  • Investors

Products & Services of Aerobiotix

Aerobiotix offers a comprehensive portfolio of products and services, including Illuvia Sense, AeroCure Vac, AeroCure 200, and GermZone Pro.

Illuvia Sense
Air Purifier

Reduces infection risk in operating rooms using UV and HEPA filtration.

AeroCure Vac
Disinfection System

Decontaminates air by removing bioaerosols and surgical smoke.

AeroCure 200
Air Disinfection

Provides continuous air purification for healthcare environments.

GermZone Pro
Filtration System

Manages air quality to minimize microbial contamination.

Apps and channels of Aerobiotix

its YouTube channel Aerobiotix has 15 subscribers and 30 videos.

Aerobiotix
YouTube 15 subscribers 30 videos Science & Technology
Open channel

Videos from Aerobiotix

The most watched videos on Aerobiotix's YouTube channel, Aerobiotix (15 subscribers). Click a video to play it here.

Episode 01: Moving the Needle on Making Healthcare Air Safer | The Healthcare Air Deep Dive Podcast
46 views
Cleaning Up the Dirty Donut®: Why Operating Room Air Isn't As Clean As It Should Be
31 views
How does the device support emergency preparedness and surge capacity?
17 views
Episode 02: The Role of Air Quality in Emergency Preparedness
13 views

More on Aerobiotix.

Funding Insights of Aerobiotix

Aerobiotix has successfully raised a total of $25M through 1 strategic funding round. The most recent funding activity was a Series A round of $25 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $25M
  • Total Rounds 1
  • Last Round Series A — $25M
  • First Round $25M

    (May 2021)

  • Investors Count 2

All 1 funding rounds of Aerobiotix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2021$25MSeries A–Vivo Capital
Valuation history

2 investors in total: 2 institutional.

Investors in Aerobiotix

Aerobiotix has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Vivo Capital and Asahi Kasei Ventures.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Venture capital and private equity firm
vivocapital.comPalo Alto, United States
Innovative global companies are supported through venture capital investments by Asahi Kasei Ventures.
1922asahikaseiventures.comTokyo, Japan
Premium access

Investor details for Aerobiotix

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Aerobiotix

15 people are tracked at Aerobiotix (7 in leadership, 8 in team).

NameRoleGroup
David Kirschman
Founder & Chief Scientific OfficerLeadership
Michael L Schmitz
President / Chief Financial OfficerLeadership
Michael Schmitz
CFOLeadership
Paul Ciovacco
Vice President Of Global SalesLeadership
Anthony Collias
General Manager EMEALeadership
Julie Smith
Human Resources DirectorLeadership
David Letteri
Director of Quality Assurance/Regulatory AffairsLeadership
Thomas Gates, Jr.
Award Winning Area Sales ManagerTeam
Heidi Bates
Area Sales ManagerTeam
CJ Neumann
Area Sales ManagerTeam
Maria Revels
Manager, Sales and Marketing SupportTeam
Erick Convery
Area Sales ManagerTeam
Chris Remala
Regional Sales ManagerTeam
John Damer
Sales AgentTeam
Jayne Rewucki
Area Sales ManagerTeam
Premium access

Complete people profiles for Aerobiotix

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Aerobiotix

2 dated milestones of Aerobiotix across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded Aerobiotix is founded.
  2. Funding First funding round of $25.0M.

Competitors of Aerobiotix

Aerobiotix has 3 listed competitors in our database, 3 of them funded. They include R-Zero, Crystal IS and RayVio.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
rzero.com2020San Francisco, United States$162.4M
UV-C disinfection devices for hospital infection control are developed.
cisuvc.com1997Albany, United States$15.23M
Ultraviolet light-emitting diodes are provided using aluminum nitride technology.
rayvio.com2012Hayward, United States$35.3M9
Provides educational content on online slots and gaming strategies.
Premium access

Detailed competitors of Aerobiotix

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Medical Equipment & Supplies

3 companies that operate in the same segment as Aerobiotix (Medical Equipment & Supplies) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Robotic waterjet system for prostate tissue removal is developed.
2009Redwood City, California, United StatesUSD 348.84 MUSD 308.05 M756
Robotic microsurgical systems for endoscopy are developed.
2007Redwood City, California, United StatesUSD 733.62 M91
Injectable packaging, containment, and delivery solutions are manufactured.
1923Exton, Pennsylvania, United StatesUSD 8.15 B6,357
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Aerobiotix

Premium access

Complete news archive for Aerobiotix

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aerobiotix

Aerobiotix was founded in 2013 and raised its 1st funding round 8 years after it was founded.

Aerobiotix is headquartered in United States. It is registered at Ohio, United States.

Aerobiotix is a funded company, having raised a total of $25M across 1 funding round to date. The company's 1st funding round was a Series A of $25M, raised on May 2021.

Provider of UV-based disinfection systems for hospitals and other establishments. The products in Healthcare include Illuvia (air treatment systems), GermZone (upper room UV air Germicidal Systems), and GermVac (Negative pressure germicidal system). The Homecare product contains physician-designed laboratory-proven technology- Aerocure. The HVAC product is the Ultra V 250UV. The first product of the company was Tower One (T1) designed for air purification and disinfection system.

Aerobiotix's top competitors include R-Zero, Crystal IS and RayVio.

Aerobiotix offers Illuvia Sense, AeroCure Vac, AeroCure 200, and GermZone Pro.

Aerobiotix has 2 investors. Key investors include Vivo Capital, and Asahi Kasei Ventures.

Aerobiotix operates through Aerobiotix, Llc.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available